发明名称 |
FACTOR VIII: REMODELING AND GLYCOCONJUGATION OF FACTOR VIII |
摘要 |
The invention includes methods and compositions for remodeling a peptide molecule, including the addition or deletion of one or more glycosyl groups to a peptide, and/or the addition of a modifying group to a peptide. |
申请公布号 |
US2016200795(A1) |
申请公布日期 |
2016.07.14 |
申请号 |
US201514974841 |
申请日期 |
2015.12.18 |
申请人 |
Novo Nordisk A/S |
发明人 |
DeFrees Shawn;Zopf David A.;Bayer Robert J.;Bowe Caryn;Hakes David James;Chen Xi |
分类号 |
C07K14/755;A61K47/48;A61K38/37;C07K1/107 |
主分类号 |
C07K14/755 |
代理机构 |
|
代理人 |
|
主权项 |
1. A covalent conjugate comprising Factor VIII and a linear or a branched poly(ethylene glycol), wherein the a linear or a branched poly(ethylene glycol) is conjugated directly onto the peptide backbone of Factor VIII or conjugated onto the peptide backbone of Factor VIII via a linker, wherein the in vivo half-life of the conjugate is increased by at least about 40% compared to the in vivo half-life of a wild-type Factor VIII, wherein the linear or branched poly(ethylene glycol) has a degree of polymerization of from about 1 to about 5,000. |
地址 |
Bagsvaerd DK |